| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Department of Urology, Osaka University Medical School [M. Nozaw., N. K., N. N., T. M., A. O.] and Department of Science for Laboratory Animal Experimentation, Research Institute for Microbial Diseases [M. Nozaw., K. Y., Y. N., M. Nozak.], Osaka University, Osaka 565-0871, Japan
We recently cloned a novel transcription factor gene, hPSE, which belongs to the Ets gene family. hPSE mRNA was expressed specifically in prostate glandular epithelial cells and also in the human prostate carcinoma cell lines PC-3 and LNCaP. On the other hand, on immunoblot analysis with anti-hPSE antiserum, hPSE protein was detected only in human prostate tissue samples and not in PC-3 or LNCaP culture cells. Immunohistochemistry and in situ hybridization analysis revealed that hPSE protein was translated in normal prostate glandular epithelial cells, but not in carcinoma cells with hPSE transcripts. These findings suggest that expression of hPSE is regulated translationally in prostate epithelial cells and that hPSE protein is a candidate for a marker distinguishing normal cells from cancer cells in the prostate. It appeared that the 5'- and 3'-untranslated regions of hPSE transcripts might be necessary for translational control of hPSE, on the basis of results of transfection analysis in non-prostate lineage cells (HEK-293) using some deletion mutants of hPSE cDNA.
This article has been cited by other articles:
![]() |
V. J. Findlay, D. P. Turner, O. Moussa, and D. K. Watson MicroRNA-Mediated Inhibition of Prostate-Derived Ets Factor Messenger RNA Translation Affects Prostate-Derived Ets Factor Regulatory Networks in Human Breast Cancer Cancer Res., October 15, 2008; 68(20): 8499 - 8506. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Turner, V. J. Findlay, A. D. Kirven, O. Moussa, and D. K. Watson Global Gene Expression Analysis Identifies PDEF Transcriptional Networks Regulating Cell Migration during Cancer Progression Mol. Biol. Cell, September 1, 2008; 19(9): 3745 - 3757. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Turner, O. Moussa, M. Sauane, P. B. Fisher, and D. K. Watson Prostate-Derived ETS Factor Is a Mediator of Metastatic Potential through the Inhibition of Migration and Invasion in Breast Cancer Cancer Res., February 15, 2007; 67(4): 1618 - 1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Wallace, M. I. Block, W. Gillanders, J. Ravenel, B. J. Hoffman, C. E. Reed, M. Fraig, D. Cole, and M. Mitas Accurate Molecular Detection of Non-small Cell Lung Cancer Metastases in Mediastinal Lymph Nodes Sampled by Endoscopic Ultrasound-Guided Needle Aspiration Chest, February 1, 2005; 127(2): 430 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Maeda, S. Nagata, C. D. Wolfgang, G. L. Bratthauer, T. K. Bera, and I. Pastan The T Cell Receptor {gamma} Chain Alternate Reading Frame Protein (TARP), a Prostate-specific Protein Localized in Mitochondria J. Biol. Chem., June 4, 2004; 279(23): 24561 - 24568. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Galang, W. J. Muller, G. Foos, R. G. Oshima, and C. A. Hauser Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors J. Biol. Chem., March 19, 2004; 279(12): 11281 - 11292. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Feldman, V. I. Sementchenko, M. Gayed, M. M. Fraig, and D. K. Watson Pdef Expression in Human Breast Cancer Is Correlated with Invasive Potential and Altered Gene Expression Cancer Res., August 1, 2003; 63(15): 4626 - 4631. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Johnson, R. P. Walker, S. W. Jones, K. Stephens, J. Meurer, D. A. Zajchowski, M. M. Luke, F. Eeckman, Y. Tan, L. Wong, et al. Multiplex Gene Expression Analysis for High-Throughput Drug Discovery: Screening and Analysis of Compounds Affecting Genes Overexpressed in Cancer Cells Mol. Cancer Ther., December 1, 2002; 1(14): 1293 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Seki, M. A. Suico, A. Uto, A. Hisatsune, T. Shuto, Y. Isohama, and H. Kai The ETS Transcription Factor MEF Is a Candidate Tumor Suppressor Gene on the X Chromosome Cancer Res., November 15, 2002; 62(22): 6579 - 6586. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. R. Thompson, J. W. Harris, B. J. Wold, S. R. Quake, and J. P. Brody Identification and Confirmation of a Module of Coexpressed Genes Genome Res., October 1, 2002; 12(10): 1517 - 1522. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Meng, A. Shan, L. Jin, and C. Y. F. Young The Expression of a Variant Prostate-specific Antigen in Human Prostate Cancer Epidemiol. Biomarkers Prev., March 1, 2002; 11(3): 305 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ghadersohi and A. K. Sood Prostate Epithelium-derived Ets Transcription Factor mRNA Is Overexpressed in Human Breast Tumors and Is A Candidate Breast Tumor Marker and A Breast Tumor Antigen Clin. Cancer Res., September 1, 2001; 7(9): 2731 - 2738. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |